De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

AdaptHealth Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Suzanne Foster

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.3yrs
Gemiddelde ambtstermijn bestuur	4.3yrs

Recente managementupdates

Recent updates

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Sep 06

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

Jul 14

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Mar 07

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Feb 16

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Jan 18

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

Nov 15

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Oct 18

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Sep 27

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Jul 19

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Jul 04

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Jun 16

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Apr 10

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Mar 22

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Feb 23

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Jan 24

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Dec 16

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Nov 28

AdaptHealth named a Fresh Pick at Baird after investor day

Sep 19

AdaptHealth: Operating Performance Stretching Up, Valuation Less So

Aug 30

AdaptHealth Q2 2022 Earnings Preview

Aug 08

AdaptHealth gains ahead of addition to S&P SmallCap 600

Aug 02

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Jun 27

AdaptHealth: Strongest Home DME Distributor, But Industry Outlook Weak

May 19

CEO

Suzanne Foster (54 yo)

less than a year

Tenure

Ms. Suzanne M. Foster, M.Ed, MPH, serves as Chief Executive Officer at Adapt health LLC since May 2024 and serves as its Director since 2024 and serves as Chief Executive Officer at Adapt health corp since...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jason Clemens	Chief Financial Officer	4.2yrs	US$2.38m	0.13% $ 1.8m
Albert Prast	Chief Technology Officer	3.8yrs	US$1.80m	0.054% $ 768.5k
Shaw Rietkerk	Chief Business Officer	less than a year	US$1.53m	0.16% $ 2.3m
Suzanne Foster	Chief Executive Officer & Director	less than a year	geen gegevens	geen gegevens
Scott Barnhart	Chief Operating Officer	less than a year	geen gegevens	geen gegevens
Christie Archbold	Chief Accounting Officer	1.6yrs	geen gegevens	0.0047% $ 66.3k
Nalin Narayanam	Chief Information Officer	less than a year	geen gegevens	geen gegevens
Wendy Russalesi	Chief Compliance Officer	2.8yrs	geen gegevens	geen gegevens
Jonathan Bush	General Counsel	less than a year	geen gegevens	geen gegevens
Leila Vargas	Executive Vice President of Sales & Marketing	2.3yrs	geen gegevens	geen gegevens
Joel Mills	Chief People Officer	2.8yrs	geen gegevens	geen gegevens
Briah Carey	President of Diabetes	less than a year	geen gegevens	geen gegevens

1.3yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van AHCO wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.6 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Suzanne Foster	Chief Executive Officer & Director	less than a year	geen gegevens	geen gegevens
Dale Wolf	Independent Chairman of the Board	4.9yrs	US$297.58k	0.073% $ 1.0m
Theodore Lundberg	Independent Director	3.7yrs	US$287.58k	0.64% $ 9.0m
Gregory Belinfanti	Independent Director	3.1yrs	US$277.58k	0.035% $ 493.2k
Bradley Coppens	Independent Director	4.3yrs	US$306.67k	0.043% $ 608.2k
David Williams	Independent Director	4.3yrs	US$277.58k	0.028% $ 400.8k
Susan Weaver	Independent Director	6.7yrs	US$287.58k	0.056% $ 798.0k
Terence Connors	Independent Director	4.9yrs	US$307.58k	0.042% $ 596.4k
Joshua Parnes	Director	4.9yrs	US$4.05m	0.50% $ 7.1m

4.3yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AHCO wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).

AdaptHealth Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

AdaptHealth Corp. Appoints Diana Nole to Board of Directors

Insufficient new directors

Insider recently sold US$281k worth of stock

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

AdaptHealth Corp. Announces Changes to Board of Directors and Management

Recent updates

AdaptHealth Corp. Appoints Diana Nole to Board of Directors

AdaptHealth Corp. to Report Q3, 2024 Results on Nov 05, 2024

Insufficient new directors

Insider recently sold US$281k worth of stock

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for the Fiscal Year 2024

AdaptHealth Corp. to Report Q2, 2024 Results on Aug 06, 2024

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

AdaptHealth Corp. Announces Changes to Board of Directors and Management

Levi & Korsinsky LLP Encourages to File a Claim Against the Settlement Fund Before Deadline Against Adapthealth Corp

AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement

Jerry W. Ray V. AdaptHealth Corp. Class Action Reaches Important Milestones

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Investor sentiment improves as stock rises 18%

Adapthealth Corp. Announces CEO Changes

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Consensus EPS estimates increase by 13%, revenue downgraded

First quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 19% to US$17.83

AdaptHealth Corp. Announces Stephen Griggs Not to Seek Re-Election to the Board

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 35%

Investor sentiment deteriorates as stock falls 32%

Price target decreased by 17% to US$23.60

Full year 2022 earnings: EPS misses analyst expectations

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Insider recently sold US$941k worth of stock

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Insider recently sold US$4.0m worth of stock

AdaptHealth Corp. to Report Q4, 2022 Results on Feb 28, 2023

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet